Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)

被引:26
|
作者
Bookhout, Christine [1 ]
Bouldin, Thomas W. [1 ]
Ellison, David W. [2 ]
机构
[1] Univ N Carolina, Dept Surg Pathol, Chapel Hill, NC 27599 USA
[2] St Jude Childrens Res Hosp, Dept Neuropathol, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
atypical teratoid; rhabdoid tumor; BRG1; INI1; SMARCA4; SMARCB1; CENTRAL-NERVOUS-SYSTEM; MALIGNANT RHABDOID TUMOR; SMALL-CELL-CARCINOMA; PREDISPOSITION SYNDROME; HYPERCALCEMIC TYPE; HSNF5/INI1; MUTATIONS; GERMLINE; CLASSIFICATION; PROGNOSIS;
D O I
10.1111/neup.12452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, highly aggressive malignancy of the central nervous system (CNS) usually diagnosed in infancy or childhood, most often characterized by loss of expression of the SMARCB1 gene product integrase interactor 1 (INI1) protein. We report a case of AT/RT in a 3month old boy with retained expression of INI1 by immunohistochemistry. Additional testing demonstrated loss of expression of the SMARCA4 gene product Brahma-related gene 1 (BRG1) protein by immunohistochemistry, confirmed by next generation sequencing showing a nonsense mutation in SMARCA4. This case illustrates that positivity for INI1 does not rule out a diagnosis of AT/RT, and additional testing, including BRG1/SMARCA4 analysis, is warranted in cases where clinical suspicion is high.
引用
收藏
页码:305 / 308
页数:4
相关论文
共 50 条
  • [21] Reduced expression of SMARCB1/INI1 protein in synovial sarcoma
    Kohashi, Kenichi
    Oda, Yoshinao
    Yamamoto, Hidetaka
    Tamiya, Sadafumi
    Matono, Hiroshi
    Iwamoto, Yukihide
    Taguchi, Tomoaki
    Tsuneyoshi, Masazumi
    MODERN PATHOLOGY, 2010, 23 (07) : 981 - 990
  • [22] Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
    Rajiv Pathak
    Francesca Zin
    Christian Thomas
    Susanne Bens
    Tenzin Gayden
    Jason Karamchandani
    Roy W. Dudley
    Karolina Nemes
    Pascal D. Johann
    Florian Oyen
    Uwe Kordes
    Nada Jabado
    Reiner Siebert
    Werner Paulus
    Marcel Kool
    Michael C. Frühwald
    Steffen Albrecht
    Ganjam V. Kalpana
    Martin Hasselblatt
    Acta Neuropathologica, 2021, 142 : 361 - 374
  • [23] SMARCB1/INI1 inactivation in renal medullary carcinoma
    Calderaro, Julien
    Moroch, Julien
    Pierron, Gaelle
    Pedeutour, Florence
    Grison, Camille
    Maille, Pascale
    Soyeux, Pascale
    de la Taille, Alexandre
    Couturier, Jerome
    Vieillefond, Annick
    Rousselet, Marie Christine
    Delattre, Olivier
    Allory, Yves
    HISTOPATHOLOGY, 2012, 61 (03) : 428 - 435
  • [24] Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
    Kohashi, Kenichi
    Izumi, Teiyu
    Oda, Yoshinao
    Yamamoto, Hidetaka
    Tamiya, Sadafumi
    Taguchi, Tomoaki
    Iwamoto, Yukihide
    Hasegawa, Tadashi
    Tsuneyoshi, Masazumi
    HUMAN PATHOLOGY, 2009, 40 (03) : 349 - 355
  • [25] SMARCB1 loss induces druggable cyclinD1deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors
    Xue, Yibo
    Zhu, Xianbing
    Meehan, Brian
    Venneti, Sriram
    Martinez, Daniel
    Morin, Genevieve
    Maiga, Rayelle, I
    Chen, Hongbo
    Papadakis, Andreas, I
    Johnson, Radia M.
    O'Sullivan, Maureen J.
    Erdreich-Epstein, Anat
    Gotlieb, Walter H.
    Park, Morag
    Judkins, Alexander R.
    Pelletier, Jerry
    Foulkes, William D.
    Rak, Janusz
    Huang, Sidong
    JOURNAL OF PATHOLOGY, 2020, 252 (01) : 77 - 87
  • [26] Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases
    Sahay, Ayushi
    Kante, Katha
    Menon, Santosh
    Ghosh, Jaya
    Kerkar, Rajendra A.
    Deodhar, Kedar K.
    TURKISH JOURNAL OF PATHOLOGY, 2020, 36 (03) : 261 - 267
  • [27] SMARCB1/INI1/BAF47-deficient pleural malignant mesothelioma with rhabdoid features
    Kimura, Noriko
    Hasegawa, Masaru
    Hiroshima, Kenzo
    PATHOLOGY INTERNATIONAL, 2018, 68 (02) : 128 - 132
  • [28] INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas
    Perry, A
    Fuller, CE
    Judkins, AR
    Dehner, LP
    Biegel, JA
    MODERN PATHOLOGY, 2005, 18 (07) : 951 - 958
  • [29] Second rhabdoid tumor 8 years after treatment of atypical teratoid/rhabdoid tumor in a child with germline SMARCB1 mutation
    Bhatt, Mihir D.
    Al-Karmi, Salma
    Druker, Harriet
    Gupta, Abha
    Lu, Mei
    Malkin, David
    Somers, Gino
    Huang, Annie
    Bouffet, Eric
    PEDIATRIC BLOOD & CANCER, 2019, 66 (03)
  • [30] SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis
    Hulsebos, T. J. M.
    Kenter, S. B.
    Jakobs, M. E.
    Baas, F.
    Chong, B.
    Delatycki, M. B.
    CLINICAL GENETICS, 2010, 77 (01) : 86 - 91